CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity

Journal of Clinical Investigation

Volumn 97, Issue 9, 1996, Pages 2027-2037

  Schmidt, Dorle ^a   Goronzy, Jörg J ^a   Weyand, Cornelia M ^a  

^a MAYO CLINIC   (United States)

Author keywords

autoimmunity; clonal expansion; rheumatoid arthritis; T cell receptor; T cells

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CELL CLONE; CLONAL ANERGY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; T LYMPHOCYTE SUBPOPULATION;

EID: 0029958821     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118638     Document Type: Article

References (41)

1. van Boxel, J.A., and S.A. Paget. 1975. Predominantly T cell infiltrate in rheumatoid synovial membranes. N. Engl. J. Med. 293:517-520.
2. Harris, E.D., Jr. 1990. Rheumatoid arthritis. Pathophysiology and implications for therapy. N. Engl. J. Med 322:1277-1289.
3. Wordsworth, P., K.D. Pile, J.D. Buckely, J.S. Lanchbury, B. Ollier, M. Lathrop, and J.I. Bell. 1992. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am. J. Hum. Genet. 51:585-591.
4. Weyand, C.M., C. Xie, and J.J. Goronzy. 1992. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J. Clin. Invest. 89:2033-2039.
5. Walser-Kuntz, D.R., C.M. Weyand, A.J. Weaver, W.M. O'Fallon, and J.J. Goronzy. 1995. Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. Immunity. 2:597-605.
6. + T cells in rheumatoid arthritis. J. Clin. Invest. 94:2068-2076.
7. Waase, I., C. Kayser, P.J. Carlson, J.J. Goronzy, and C.M. Weyand. 1996. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum. In press.
8. Choi, Y., B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler. 1989. Interaction of Staphylococcus aureus toxin "super antigens" with human T cells. Proc. Natl. Acad. Sci. USA. 86:8941-8945.
9. Stoflet, E.S., D.D. Koeberl, G. Sarkar, and S.S. Sommer. 1988. Genomic amplification with transcript sequencing. Science (Wash. DC). 239:491-494.
10. Morishita, Y., H. Sao, J.A. Hansen, and P.J. Martin. 1989. A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire. J. Immunol. 143:2783-2789.
11. Reinhold, U., H. Abken, S. Kukel, M. Moll, R. Muller, I. Oltermann, and H.W. Kreysel. 1993. CD7- T cells represent a subset of normal human blood lymphocytes. J. Immunol. 150:2081-2089.
12. Jenkins, M.K., and J.G. Johnson. 1993. Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 5:361-367.
13. Linsley, P., and J. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
14. Rothstein, D.M., A. Yamada, S.F. Schlossman, and C. Morimoto. 1991. Cyclic regulation of CD45 isoform expression in a long term human CD4+ CD45RA+ T cell line. J. Immunol. 146:1175-1183.
15. Bell, E.B., and S.M. Sparshott. 1990. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature (Lond.). 348:163-166.
16. - T cells in mice and humans. J. Exp. Med. 180:1097-1106.
17. Bendalac, A., N. Killeen, D.R. Littman, and R.H. Schwartz. 1994. A subset of CD4+ thymocytes selected by MHC class I molecules. Science (Wash. DC). 263:1774-1778.
18. Lazarovits, A.I., M.J. White, and I. Karsh. 1992. CD7- T cells in rheumatoid arthritis. Arthritis & Rheum. 35:615-624.
19. Legac, E., B. Autran, H. Merle-Beral, C. Katlama, and P. Debre. 1992. CD4+ CD7- CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood. 79:1746-1753.
20. Autran, B., E. Legac, C. Blanc, and P. Debre. 1995. A Th0/Th2-like function of CD4+ CD7- T helper cells from normal donors and HIV-infected patients. J. Immunol. 154:1408-1417.
21. Haynes, B.F., R.S. Metzger, J.D. Minna, and P.A. Bunn. 1981. Phenotypic characterization of cutaneous T-cell lymphoma: use of monoclonal antibodies to compare with other malignant T cells. N. Engl. J. Med. 304:1319-1323.
22. Moll, M., U. Reinhold, S. Kukel, H. Abken, R. Muller, I. Oltermann, and H.W. Kreysel. 1994. CD7-negative helper T cells accumulate in inflammatory skin lesions. J. Invest. Dermatol. 102:328-332.
23. Azuma, M., J.H. Phillips, and L.L. Lanier. 1993. CD28- T lymphocytes. Antigenic and functional properties. J. Immunol. 150:1147-1159.
24. Posnett, D.N., R. Sinha, S. Kabak, and C. Russo. 1994. Clonal populations of T cells in normal elderly humans. The T cell equivalent to "benign monoclonal gammapathy." J. Exp. Med. 179:609-618.
25. Hingorani, R., I.-H. Choi, P. Akolkar, B. Gulwani-Akolkar, R. Pergolizzi, J. Silver, and P.K. Gregersen. 1993. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J. Immunol. 151:5762-5769.
26. Morley, J.K., F.M. Batliwalla, R. Hingorani, and P.K. Gregersen. 1995. Oligoclonal CD8+ T cells are preferentially expanded in the CD57 subset. J. Immunol. 154:6182-6190.
27. DerSimonian, H., M. Sugita, D.N. Glass, A. Maier, M.E. Weinblatt, T. Reme, and M.B. Brenner. 1993. Clonal Vα12.1 T cell expansion in the peripheral blood of rheumatoid arthritis patients. J. Exp. Med. 177:1623-1631.
28. Fitzgerald, J.E., N.S. Ricalton, A.-C. Meyer, S.G. West, H. Kaplan, C. Behrendt, and B.L. Kotzin. 1995. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J. Immunol. 154: 3538-3547.
29. Cohen, J.J., R.C. Duke, V.A. Fadok, and K.S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267-293.
30. Dhein, J., H. Walczak, C. Baumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (Lond.). 373:438-441.
31. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373:441-444.
32. Ju, S.-T., D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (Lond.). 373: 444-448.
33. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249-1256.
34. Moskophidis, D., F. Lechner, H. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (Lond.). 362:758-761.
35. Boise, L.H., A.J. Minn, P.J. Noel, C.H. June, M.A. Accavitti, T. Lindsten, and C.B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of bcl-x(L). Immunity. 3:87-98.
36. Akbar, A.N., N. Borthwick, M. Salmon, W. Gombert, M. Bofill, N. Shamsadeen, D. Pilling, S. Pett, J.E. Grundy, and G. Janossy. 1993. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J. Exp. Med. 178:427-138.
37. Ramsdell, F., M.S. Seaman, R.E. Miller, K.S. Picha, M.K. Kennedy, and D.H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545-1553.
38. Singer, G.G., and A.K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:365-371.
39. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
40. Lynch, D.H., M.L. Watson, M.R. Alderson, P.R. Baum, R.E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C.A. Smith, K. Hunter, et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1:131-136.
41. Jevnikar, A.M., M.J. Grusby, and L.H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179:1137-1143.